Literature DB >> 23080367

African-Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation.

Lara N Roberts1, Raj K Patel, Paradzai Chitongo, Lynda Bonner, Roopen Arya.   

Abstract

African-Caribbean ethnicity is associated with an increased risk of both first and recurrent venous thromboembolism (VTE). The aim of this study was to evaluate thrombin generation in African-Caribbeans compared with whites in patients with deep vein thrombosis (DVT) and healthy volunteers. Thrombin generation was measured in a case-control study of 80 patients who had completed anticoagulation therapy for a first DVT (50 white and 30 African-Caribbean) and 66 controls. Peak thrombin with and without thrombomodulin was significantly higher in African-Caribbeans with DVT compared with whites with DVT (P < 0.001 for both comparisons) and African-Caribbean controls (P < 0.001, 0.003, respectively). Endogenous thrombin potential (ETP) with and without thrombomodulin was significantly higher in African-Caribbeans with DVT than whites with DVT (P ≤ 0.001 for both comparisons). Maximum velocity and ETP ratio were increased in African-Caribbeans with DVT compared with whites with DVT (P < 0.001 and 0.030, respectively) and African-Caribbean controls (P < 0.001 and 0.019, respectively). Within the control group, peak thrombin was significantly increased in African-Caribbeans compared with whites (P = 0.017). ETP, peak thrombin with thrombomodulin and maximum velocity were also increased in African-Caribbeans compared with white controls (P = 0.045 for all comparisons). African-Caribbeans with DVT had significantly higher factor VIII levels compared with whites with DVT and controls. African-Caribbean ethnicity confers a hypercoagulable state as measured by thrombin generation. This supports epidemiological findings of increased risk of first and recurrent VTE. Thrombin generation requires adjustment for ethnicity in studies undertaken in ethnically diverse populations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23080367     DOI: 10.1097/MBC.0b013e32835a07fa

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  10 in total

1.  Novel genetic predictors of venous thromboembolism risk in African Americans.

Authors:  Wenndy Hernandez; Eric R Gamazon; Erin Smithberger; Travis J O'Brien; Arthur F Harralson; Matthew Tuck; April Barbour; Rick A Kittles; Larisa H Cavallari; Minoli A Perera
Journal:  Blood       Date:  2016-02-17       Impact factor: 22.113

2.  Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans.

Authors:  Laura M Raffield; Ake T Lu; Mindy D Szeto; Amarise Little; Kelsey E Grinde; Jessica Shaw; Paul L Auer; Mary Cushman; Steve Horvath; Marguerite R Irvin; Ethan M Lange; Leslie A Lange; Deborah A Nickerson; Timothy A Thornton; James G Wilson; Marsha M Wheeler; Neil A Zakai; Alex P Reiner
Journal:  J Thromb Haemost       Date:  2020-02-20       Impact factor: 5.824

3.  Coagulation activation in sickle cell trait: an exploratory study.

Authors:  Chirag Amin; Soheir Adam; Micah J Mooberry; Abdullah Kutlar; Ferdane Kutlar; Denise Esserman; Julia E Brittain; Kenneth I Ataga; Jen-Yea Chang; Alisa S Wolberg; Nigel S Key
Journal:  Br J Haematol       Date:  2015-09-07       Impact factor: 6.998

4.  Changes in thrombin generation and D-dimer concentrations in women injecting enoxaparin during pregnancy and the puerperium.

Authors:  Jignesh P Patel; Raj K Patel; Lara N Roberts; Michael S Marsh; Bruce Green; J Graham Davies; Roopen Arya
Journal:  BMC Pregnancy Childbirth       Date:  2014-11-19       Impact factor: 3.007

5.  Thrombin Generation in Acute Ischaemic Stroke.

Authors:  Ibrahim O Balogun; Lara N Roberts; Raj Patel; Rohan Pathansali; Lalit Kalra; Roopen Arya
Journal:  Stroke Res Treat       Date:  2016-12-25

6.  Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19.

Authors:  Galit H Frydman; Edward W Boyer; Rosalynn M Nazarian; Elizabeth M Van Cott; Gregory Piazza
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

7.  ST Genesia reference values of 117 healthy donors measured with STG-BleedScreen, STG-DrugScreen and STG-ThromboScreen reagents.

Authors:  Marisa Ninivaggi; Romy M W de Laat-Kremers; Audrey Carlo; Bas de Laat
Journal:  Res Pract Thromb Haemost       Date:  2020-12-19

8.  Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.

Authors:  Roshan Ramasamy; Kate Milne; Deanne Bell; Simon Stoneham; Timothy Chevassut
Journal:  Br J Haematol       Date:  2020-06-08       Impact factor: 8.615

9.  Is There Any Improvement of the Coagulation Imbalance in Sickle Cell Disease after Hematopoietic Stem Cell Transplantation?

Authors:  Laurence Rozen; Denis F Noubouossie; Laurence Dedeken; Phu Quoc Lê; Alina Ferster; Anne Demulder
Journal:  J Clin Med       Date:  2019-10-26       Impact factor: 4.241

10.  Differences in thrombin and plasmin generation potential between East African and Western European adults: The role of genetic and non-genetic factors.

Authors:  Godfrey S Temba; Nadira Vadaq; Jun Wan; Vesla Kullaya; Dana Huskens; Tal Pecht; Martin Jaeger; Collins K Boahen; Vasiliki Matzaraki; Wieteke Broeders; Leo A B Joosten; Sultana M H Faradz; Gibson Kibiki; Saskia Middeldorp; Duccio Cavalieri; Paolo Lionetti; Philip G de Groot; Joachim L Schultze; Mihai G Netea; Vinod Kumar; Bas de Laat; Blandina T Mmbaga; Andre J van der Ven; Mark Roest; Quirijn de Mast
Journal:  J Thromb Haemost       Date:  2022-02-10       Impact factor: 16.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.